Ozempic

Semaglutide, sold under the brand names Ozempic, Wegovy and Rybelsus, is an antidiabetic medication used for the treatment of type 2 diabetes and an anti-obesity medication used for long-term weight management, developed by Novo Nordisk in 2012.Semaglutide is a GLP-1 receptor agonist, meaning that it mimics the action of the human incretin glucagon-like peptide-1 (GLP-1), thereby increasing insulin secretion and increasing blood sugar disposal and improving glycemic control.

Read more in the app

Grow Your Own Ozempic? Students Engineer Plants to Produce Life-Saving Drugs

Do Ozempic and Wegovy really cause hair loss?

You could soon grow your own Ozempic-like medication - EurekAlert

New Protein Discovery Could Rival Ozempic With Fewer Side Effects

Ozempic is increasingly being linked to vision loss. What’s the truth?

Naturally occurring molecule rivals Ozempic in weight loss, sidesteps side effects - EurekAlert

Ozempic Literally Came From a Monster – And It's Not Alone

Ozempic Reduces Desire to Binge Alcohol, Suggests Amazing New Study

Strongest evidence yet that Ozempic and Wegovy reduce alcohol intake

Ozempic’s key ingredient may reduce the desire to drink alcohol

Novo Nordisk Annual Sales Jump on Demand for Ozempic and Wegovy

Ozempic-Like Drug Failed to Treat Parkinson’s Disease in Trial

Ozempic and Wegovy: Scientists Uncover New Risks of Popular Weight-Loss “Miracle Drugs”

The King of Ozempic Is Scared as Hell

Ozempic and Wegovy have heart health benefits beyond just weight loss

We'll learn about Ozempic's potential for Alzheimer's disease in 2025

Drugs like Ozempic now make up 5% of prescriptions in the US

The benefits of Ozempic and its kin may extend far beyond weight loss

Why do Ozempic and Wegovy seem to treat everything?

Drugs Like Ozempic May Have a Shrinking Effect on The Heart

Quantum Worlds »